Potential for focal magnetic resonance-guided stereotactic body radiotherapy for prostate cancer: A review
- International Journal of Radiology & Radiation Therapy
-
Laura Nethercott, Farshad Foroudi, Greg Jack, Stephen Chin, Daryl Lim Joon, Michael Chao, Sweet Ping Ng
Abstract
Prostate cancer is the most commonly diagnosed cancer among Australian men. Current whole gland radiotherapy treatment regimens are associated with known toxicities. The MR-Linac has the capability to deliver real-time visually guided radiation to enable focal therapy and reduce toxicity through decreasing radiation doses to organs at risk.
Keywords
prostate cancer, radiation oncology, MR-Linac, radiation toxicity
